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Using a novel method to evaluate multivariate genetic correlation at the locus (versus global) level, we observed 150 loci that affected multiple substance use phenotypes ( Fig. 2 and Supplementary  Table 11 ). Patterns of pleiotropy across phenotypes were highly diverse, with only three loci significantly associated with all five phenotypes. These three loci included associations implicating phosphodiesterase 4B (PDE4B) and cullin 3 (CUL3). PDE4B regulates cyclic AMP second messenger availability and thereby affects signal transduction, and it is downregulated by chronic nicotine administration in rats 12 . CUL3 has wide-ranging effects, including on ubiquination and protein degradation, and de novo mutations in CUL3 are associated with rare diseases affecting response to the mineralocorticoid aldosterone 13 , which itself is affected by smoking 14 and is associated with alcohol use 15 . In addition to testing for pleiotropy, we also used MTAG 16 to leverage the observed genetic correlations to increase power for locus discovery. Using this method, we discovered 1,193 independent, genome-wide significantly associated common variants (minor allele frequency (MAF), > 1%; AgeSmk, 173; CigDay, 89; SmkCes, 83; SmkInit, 692; DrnkWk, 156) listed in Supplementary  Table 12 and described further in the supplementary information.
Phenotypic variation accounted for by our initial 566 conditionally independent genome-wide significant variants from the initial genome-wide association study (GWAS) ranged from 0.1% (SmkCes) to 2.3% (SmkInit; see Fig. 3 ). SNP heritability calculated using linkage disequilibrium (LD) score regression 17 ranged from 4.2% for DrnkWk to 8.0% for CigDay ( Fig. 3 and Supplementary  Table 13 ), consistent with estimates made using individual-level data 18 , SNP heritabilities calculated from the largest individual contributing studies ( Supplementary Table 13 ), and prior work 19 . The results suggest that these phenotypes are highly polygenic and that the majority of the heritability is accounted for by variants below standard GWAS thresholds.
To further investigate the polygenicity, polygenic risk scores (PRS; Supplementary Table 14) were computed on the National Longitudinal Study of Adolescent to Adult Health (Add Health) 20 and the Health and Retirement Study (HRS) 21 datasets, which are representative of their birth cohorts in the United States and represent exposures to different tobacco policy environments. Add Health participants were born, on average, in 1979; average birth year in the HRS was 1938. Despite these generational differences, the polygenic score performed similarly in both samples. It accounted for approximately 1%, 4%, 1%, 4%, and 2.5% of variance in AgeSmk, CigDay, SmkCes, SmkInit, and DrnkWk, respectively, about half of the estimated SNP heritability of these traits (Fig. 3 ). More concretely, in Add Health and the HRS, respectively, a 1 s.d. increase in the CigDay risk score resulted in two and three additional daily cigarettes; a 1 s.d. increase on the SmkInit risk score resulted in a 12% and 10% increased risk of regularly smoking; and a 1 s.d. increase on the DrnkWk risk score reflected one additional drink per week in both datasets.
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use
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Cell and tissue enrichment 22 was observed across all five phenotypes within core histone marks from multiple central nervous system tissues ( Supplementary Figs. 13-15 and Supplementary  Tables 15 and 16 ). Enrichment was observed in tissues from cortical and sub-cortical regions in the central nervous system. Structure and function of these regions have been robustly associated with individual differences in frequencies, magnitudes, and clinical characteristics of alcohol use, and substance use/misuse generally, in human imaging research. Our results include significant enrichment across phenotypes and histone marks in the hippocampus 23 , inferior temporal pathways 24 , dorsolateral and medial prefrontal cortex 25 , caudate, and striatum 26 . Consistent with gene and pathway findings described below, alcohol and nicotine use affect dopaminergic and glutamatergic neurotransmission among these brain regions, compromising reward-based learning and facilitating drug-seeking behavior 26 . Enrichment within other cell or tissue groups and specific cell or tissue types included immune and liver cells, but was less consistent across analytical approaches.
We manually reviewed all of the genes implicated by the GWAS or gene-based tests (see Supplementary Tables 1-5 for the full   catalog of implicated genes and Supplementary Tables 17-21 
Fig. 1 | Genetic correlations between substance use phenotypes and phenotypes from other large GWAs.
Genetic correlations between each of the phenotypes are shown in the first five rows, with heritability estimates displayed down the diagonal. All genetic correlations and heritability estimates were calculated using LD score regression. Purple shading represents negative genetic correlations, and red shading represents positive correlations, with increasing color intensity reflecting increasing correlation strength. A single asterisk reflects a significant genetic correlation at the P < 0.05 level. Double asterisks reflect a significant genetic correlation at the Bonferroni-correction P < 0.000278 level (corrected for 180 independent tests). Note that SmkCes was oriented such that higher scores reflected current smoking, and for AgeSmk, lower scores reflect earlier ages of initiation, both of which are typically associated with negative outcomes. For each locus, the method returns the best-fitting solution of which phenotypes were associated with that locus. All loci with one or more associated phenotypes are shown here. For example, every locus associated with AgeSmk was found to be pleiotropic for other phenotypes (green, blue, red, purple, and fuchsia bars), and no locus showed association with only AgeSmk (no dark gray bar for AgeSmk). When sample sizes are unequal across phenotypes, the method also improves power for those phenotypes with smaller samples. The total numbers of loci associated with each trait (whether pleiotropic or not) from these analyses were 40 (AgeSmk), 48 (SmkCes), 72 (CigDay), 111 (DrnkWk), and 278 (SmkInit). Full information is in Supplementary Table 11 . 
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with CigDay (P = 4.0 × 10 −99 ) and SmkCes (P = 1.6 × 10 −48 ). We replicated an association signal in the alcohol metabolism gene ADH1B associated with DrnkWk, identifying in that locus 11 conditionally independently associated variants (lowest P < 2.2 × 10 −303 ). All drugs of abuse activate the mesolimbic dopamine system reward pathway 27 , and dopamine-related genes have long been popular candidate genes. We found that variants near the widely studied dopamine receptor D2 (DRD2) 28 were associated across phenotypes, including CigDay, SmkCes, and DrnkWk (P = 6.5 × 10 −12 , 1.1 × 10 −10 , and 4.9 × 10 −11 , respectively), but not with AgeSmk or SmkInit, suggesting that these variants are less relevant in early stages of nicotine use. Other specific dopamine-related genes only showed associations with smoking phenotypes, including multiple associations between CigDay and SmkCes with dopamine β -hydroxylase (DBH; P = 9.8 × 10 −24 and 1.2 × 10 −35 , respectively) 9 , an enzyme necessary to convert dopamine to norepinephrine. SmkInit was associated with variation near protein phosphatase 1 regulatory subunit 1B (PPP1R1B; P = 3.9 × 10 −8 ), a signal transduction gene that affects synaptic plasticity and reward-based learning in the striatum 29, 30 and contributes to the behavioral effects of nicotine in mice 31 . In pathway analyses, dopamine gene sets were enriched only in SmkInit, where the exemplar 'reactome dopamine neurotransmitter release cycle' pathway was enriched (P = 9.2 × 10 −5 ; Fig. 4 and Supplementary Table 18 ). Supplementary  Table 18 . The number after each name is the number of gene sets in each cluster. The matrix naturally falls into three red superclusters along the diagonal. The largest supercluster contains primarily gene sets related to neurotransmitter receptors, ion channels (sodium, potassium, calcium), learning/memory, and other aspects of central nervous system function. The middle supercluster includes gene sets defined by regulation of transcription and translation, including RNA binding and transcription factor activity. The final supercluster is composed primarily of gene sets related to development of the nervous system.
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Neuronal acetylcholine nicotinic receptors are the initial site of nicotine action in the brain and have long been implicated in nicotine use and dependence 32 . With the exception of CHRNA7, all central-nervous-system-expressed nicotinic receptor genes were significantly associated with one or more smoking phenotypes, many reported here for the first time. Enrichment was also noted for nicotinic-receptor-related pathways and genes in smoking phenotypes (Supplementary Tables 17-21 ). There was no evidence of association between nicotinic receptor genes or pathways with DrnkWk, despite the use of nicotinic receptor partial agonists (for example, varenicline) in the treatment of alcohol dependence 33 .
Associations with SmkInit highlighted structures and functions related to long-term potentiation and reward-related learning and memory, systems that affect reward processing and addiction 28, 34, 35 . Glutamate is an important neurotransmitter mediating these processes, and exemplar pathways related to glutamate were significantly enriched in SmkInit (for example, 'extracellular-glutamate-gated ion channel' , P = 9.9 × 10 −7 ; 'post-NMDA receptor activation events' , P = 5.5 × 10 −5 ; and 'DLG4 PPI subnetwork' , P = 4.5 × 10 −12 ; Supplementary Table 18 ). DLG4 affects NMDA receptors and potassium channel clusters and has a central role in glutamatergic models of reward-related learning 35 . Individual associated genes related to these pathways included glutamate ionotropic receptor NMDA type subunit 2 (GRIN2A; P = 3.4 × 10 −11 ) and homer scaffolding protein 2 (HOMER2; P = 3.1 × 10 −14 ), which affects addictive behavior in mice 35, 36 and regulates glutamate metabotropic receptor 1 (GRM1). Pathways enriched in SmkInit also included sodium-, potassium-, and calcium voltage-gated channels ( Fig. 4 and Supplementary  Table 18 ), essential to neuronal excitability and signaling.
Alcohol is known to affect glutamatergic signaling pathways 37 , and more than half of the enriched pathways for DrnkWk clustered within the exemplar 'glutamate ionotropic receptor kainate type subunit 2 (GRIK2) PPI subnetwork' ( Fig. 4 and Supplementary  Table 18 ). However, not all DrnkWk-enriched pathways involved the brain as glucose and carbohydrate processing pathways were associated with DrnkWk but no smoking phenotype, perhaps suggesting that alcohol consumption is influenced by individual differences in one's ability to process calorie-rich alcoholic beverages. Finally, we discovered variation in and around gene-rich regions, including corticotropin-releasing hormone receptor 1 (CRHR1; P = 1.6 × 10 −17 ) and urocortin (UCN; P = 8.1 × 10 −45 ), associated with DrnkWk, but not smoking. UCN encodes an endogenous ligand for CRHR1 and CRHR2 (ref. 38 ). CRH affects hormones involved in the stress response, including cortisol, and has been associated with the stress response and relapse to drug taking in animals 39, 40 .
Specific mechanisms by which implicated genes influence substance use in humans are largely unknown, even for those genes reported above involving systems, such as neurotransmission, reward-related learning and memory, and the stress response. To prioritize genes for functional experimentation, we tabulated conditionally independent genome-wide significant non-synonymous variants ( Table 1 ). In the 406 GWAS loci, 4% of sentinel variants were nonsynonymous, representing a significant enrichment (P = 2.5 × 10 −10 ; 0.4% of variants with MAF > 0.1% in the imputation panel 41 were non-synonymous). Several genes in Table 1 have been previously associated with substance use/addiction (see Supplementary Table 22 for a list of previous associations), and two variants have been functionally validated (rs1229984 and rs16969968) 42, 43 . The others have The sentinel variant in approximately 4% of loci was non-synonymous. Shown here are all non-synonymous sentinel variants, and all non-synonymous variants in near-perfect LD with a sentinel variant. If the listed gene was also associated (through single variant or gene-based test) with another phenotype, that phenotype is listed in parentheses. Several genes have been implicated in previous studies of substance use/addiction, including CHRNA5, BDNF, GCKR, and ADH1B. Phenotype abbreviations are defined in Fig. 1 . Chr, chromosome; REF, reference allele; ALT, alternate allele; AF, allele frequency of ALT; Q, Cochrane's Q statistic P value. a These variants were not themselves sentinel, but were in near-perfect LD with a sentinel variant (r 2 > 0.99, from the 1000 Genomes European population). The scale of Beta is on the unit of the standard deviation of the phenotype. For binary phenotypes the standard deviation was calculated from the weighted average prevalence across all studies included in the metaanalysis (available in Supplementary Table 7 ).
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Nature GeNetics not, but in some cases their genes interact with established molecular targets of addiction and may themselves be suitable targets for further investigation. For example, rs1024323 in G-protein-coupled receptor kinase 4 (GRK4) was associated with CigDay (P = 8.7 × 10 −9 ) and lies within a locus associated with AgeSmk. GRK4 is involved in the regulation of G-protein-coupled receptors, including metabotropic glutamate receptor 1 (GRM1) 44 , GABA B receptors 45 , and dopamine receptors D1 (DRD1) and D3 (DRD3) in the kidneys and cerebellum, and is involved in essential hypertension 46 . GRK4 is also expressed in the midbrain and forebrain 46, 47 , but no research has evaluated its impact on substance use behavior. To take one more example, the non-synonymous variant in SLC39A8 affects zinc and manganese transport, is highly pleiotropic for complex phenotypes, and may impair inflammation, glutamatergic neurotransmission, and regulation of various metals in the body 48 . Ultimately, substance use is embedded in a complex web of causal relations 49 (for example, see Fig. 1 ), and caution must be exercised in drawing strong causal conclusions. However, our findings represent a major step forward in understanding the etiology of these complex, disease-relevant behaviors. In particular, statistical and interpretive power were both enabled by simultaneously studying multiple related substance use behaviors representing different stages of use and different substances. More precise measurements, including evaluating age and environment as moderators for these dynamic phenotypes 50 , functional research, and complementary gene mapping approaches (for example, sequencing) will aid in the discovery of mechanisms by which implicated genes may affect substance use and related disease risk. 
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Methods Generation of summary statistics. Participants in all studies were genotyped on genome-wide arrays. The majority of studies imputed their genotypes to the Haplotype Reference Consortium 41 using the University of Michigan Imputation Server (see URLs) 51 . Several studies did not impute using the imputation server, due to data sharing restrictions, computational limitations, and/or resource limitations (described in the Supplementary Note). All studies used either Minimac3 51 or IMPUTE2 52 for imputation.
GWAS summary statistics were generated in each study sample using RVTESTS 53 according to a standard analysis plan. Studies composed primarily of classically related individuals (for example, family studies) first regressed out covariates including genetic principal components under a linear model, inverse-normalized the residuals (except for 23andMe), and tested for an additive effect of each variant under a linear mixed model with a genetic kinship matrix. Family studies followed this analysis for all phenotypes, even binary phenotypes such as smoking initiation and cessation. Studies of entirely classically unrelated individuals followed the same analysis for quasi-continuous phenotypes (AgeSmk, CigDay, DrnkWk), but estimated additive genetic effects under a logistic model for binary phenotypes (SmkInit and SmkCes).
Quality control checks were applied to ensure quality of both the phenotypes and the genotypes. For each phenotype and covariate, distribution statistics including the minimum, maximum, quartiles, median, mean, and standard deviation were examined. We ensured that these statistics were within expected limits given the phenotype definitions and any scale transformations per the analysis plan. We also evaluated simple relationships among phenotypes. When discrepancies were noted, we contacted the original study for clarification or re-analysis, or the data were removed from further analysis. Phenotypic statistics are presented in Supplementary Tables 6 and 7 .
Extensive genetic quality control and filtering were performed on the contributed summary statistics from each cohort. We removed imputed variants with imputation quality less than 0.3 (the estimated squared correlation between the imputed dosage and true dosage). We compared the per-study allele labels and allele frequencies with those of the imputation reference panels and removed or reconciled mismatches. For quantitative traits, we plotted the variance of the score statistics against the sample size and tested whether the trait residuals in each study were properly normalized and whether the trait analyzed between studies was measured and analyzed using the same unit.
Meta-analysis. Meta-analysis was performed centrally using the software package rareGWAMA (see URLs). All statistical tests in the meta-analysis or secondary analyses of the meta-analytic results (for example, PRS, functional enrichment, MTAG, GenomicSEM) were two-sided. Given that rarer variants and/or behavioral phenotypes may show between-study heterogeneity in allele frequencies, imputation qualities, or genetic architecture, we extended existing methods and developed a novel fixed effects approach that accounts for between-study heterogeneity. Specifically, the methods aggregated weighted Z-score statistics, that is,
, where Z k is the Z-score statistic in study k. The weight
where p k is the variant allele frequency, R k 2 is the imputation quality, and N k is the sample size for study k. Under the null and with the present sample sizes, Z META is normally distributed. The weights are proportional to the sample genotype variance. When the trait is uniformly measured and the allele frequencies are similar, the method is approximately equivalent to meta-analysis of sample-size-weighted Z scores. Yet the method accounts for between-study heterogeneity in imputation accuracy and allele frequencies. The use of a fixed effects model, the most common approach in GWAS meta-analysis of single-ancestry groups, appeared acceptable given the apparent lack of substantial meta-analytic effect heterogeneity (see Cochrane's Q and I 2 statistics in Supplementary Tables 1-5 ). Population stratification and cryptic relatedness were addressed during the generation of summary statistics by each local study through the use of kinshipbased linear mixed models 54 and genetic principal components 55 . Residual stratification was further corrected at the meta-analytic level with study-specific genomic controls 56 (calculated separately for variants with MAF ≥ 1% and 0.1% ≤ MAF < 1%; Supplementary Table 23 ) applied to each study's results prior to meta-analysis.
A locus was defined as a 1-Mb region surrounding the 'sentinel' variant (the variant in the locus with the lowest P value). When any two such loci overlapped or abutted, they were collapsed into a single locus. Variants within each locus were subjected to conditional analysis using a novel partial correlation-based score statistic using cohort-level summary statistics 57 implemented in a sequential forward selection framework. The method requires marginal association statistics and approximated covariance matrices among them and performs favorably compared with existing methods 57 ( Supplementary Table 24 ). Covariances among effects were based upon the linkage disequilibrium information estimated from a subset of the Haplotype Reference Consortium 41 .
We applied multiple post-meta-analysis variant filters to ensure robustness of reported findings. To reduce artifacts arising from a small number of studies, we excluded any variant that was present in only two or fewer studies. For each variant in the meta-analysis, we calculated the effective sample size = ∑ N Nr
where N k is the sample size in study k and r k 2 is the imputation quality. We removed variants with effective sample sizes < 10% of the total sample size to ensure only well-imputed variants with a modicum of power were included. We also excluded all variants with MAF > 0.001, the lower bound of moderate imputation accuracy with the current best available imputation reference panel 41 . Variants with MAF > 1% are expected to be imputed with high accuracy. Results from the application of post-meta-analysis filters are displayed in Supplementary Table 25 .
After applying variant filters and obtaining our final meta-analytic results, we calculated genomic controls and maximum/median per-variant sample sizes. Sample sizes ranged from 337,334 for cigarettes per day to 1,232,091 for smoking initiation. Quantile-quantile plots, LD intercept tests, and genomic control values indicate that Type I error rates were well controlled for common and low-frequency variants ( Supplementary Fig. 2 and Supplementary Table 26 ). All conditionally independent variants were plotted in LocusZoom and included in Supplementary Figs. 1-12 . All plots were visually inspected, and suspicious loci were identified (see Supplementary Table 27 ) and removed from further consideration. To ensure LD information was available between sentinel variants and others in the locus, we used surrogate variants for eight loci (Supplementary Table 28 ).
We estimated the extent of pleiotropy for each genome-wide associated locus from our GWAS using an empirical Bayes approach (that is, whether a given locus is simultaneously associated with multiple phenotypes). Using summary association statistics from a given locus as input, the method estimated the 5 × 5 genetic correlation of the locus and the posterior probability of association for all possible phenotype configurations, while accounting for genome-wide genetic correlations and trait residual correlations. In cases in which loci associated with different phenotypes overlapped, the locus was expanded in size. Statistical details are available in Section 3.3 of the Supplementary Note.
We applied MTAG 16 to variants with MAF > 1% from the final meta-analysis results for each phenotype, using the other four phenotypes to increase power for locus discovery. Genomic controls and LD intercept tests of the MTAG results were well controlled ( Supplementary Table 29 ), and Manhattan and quantile-quantile plots were well behaved ( Supplementary Figs. 16 and 17 ). GCTA-COJO 58 was used to identify conditionally independent variants (listed in Supplementary Table 12 ). All loci were plotted with LocusZoom and visually inspected, with suspicious loci identified (for example, those without LD support; see Supplementary Table 30 ) and removed from further consideration. Additional details, including testing of MTAG model assumptions, are provided in the Supplementary Note. Finally, we also applied GenomicSEM 59 to our five phenotypes to formally model and factor their correlation structure. See Supplementary Fig. 18 , Supplementary Table 31 , and the Supplementary Note for further details.
Genome-wide significance threshold. The primary focus was to test variants with MAF ≥ 1%, as these will be imputed with high confidence. The statistical significance threshold applied to meta-analysis of all variants with MAF ≥ 1% was 5 × 10 −8 , consistent with widespread convention in GWAS of European individuals. Since our imputation procedure is expected to provide some marginal level of accuracy down to MAF of 0.1%, we also conducted an exploratory association test for low-frequency variants with 0.1% < MAF < 1%, to which we applied a statistical significance threshold of P < 5 × 10 −9 . Only two such low-frequency variants surpassed the conventional common variant threshold of P < 5 × 10 −8 . Of these two, one low-frequency variant, associated with SmkInit, survived the more stringent multiple testing correction (rs181508347, intergenic, MAF = 0.0096, P = 5 × 10 −10 ), and it is included in our count of discovered loci and listed in Supplementary  Table 4 . The more stringent threshold applies a correction for ~10 million tests, which is approximately the number of conditionally independent variants tested once the MAF lower bound was extended from 1% to 0.1%. We calculated this threshold using three existing methods [60] [61] [62] . These methods make use of the eigenvalues of the matrix of LD (measured in R 2 ) between SNPs, calculated with a spectral decomposition. We estimated the number of independent tests using the genotype data from a subset of the Haplotype Reference Consortium panel 41 . We first calculated LD blocks across the genome using the algorithm implemented in PLINK v.1.9 63 with default settings, and then we lowered the MAF threshold to 0.1% to accommodate all low-frequency variants. Next, we calculated the effective number of independent tests within each LD block and between LD blocks using the aforementioned three methods, which we aggregated to get the total number of independent tests. The three techniques estimated the number of independent variants at 9.8 million to 10.1 million independent tests, similar to other independent estimates 64 . A total of 278 sentinel variants (including the one genome-wide significant low-frequency variant) had P < 5 × 10 −9 , out of the original 406 with P < 5 × 10 −8 .
Heritability. We used univariate and bivariate LD score regression 17 to assess the heritability of each phenotype and to estimate a variety of genetic correlations. Analyses included (1) LD score regression intercept tests to evaluate the extent to which population stratification or cryptic relatedness may artificially inflate our summary statistics; (2) estimation of genetic correlations across our five phenotypes; (3) estimation of genetic correlations computed within a phenotype but between the larger contributing studies, as an estimate of the extent to which phenotypes were measuring the same genetic risk in different studies; and (4) estimation of genetic correlation between the five phenotypes and a wide variety of other phenotypes related to smoking and alcohol behaviors, and for which GWAS have already been made publicly available.
Under standard assumptions, bivariate score regression produces unbiased estimates of genetic correlation, even in the presence of sample overlap 65 . Accordingly, to estimate the extent of genetic correlation between each of our phenotypes, and between our phenotypes and other phenotypes related to nicotine and alcohol use, we used standard procedures in LD score regression 22 . To be included in these analyses, variants were restricted to those present in HapMap3 with MAF > 0.01. Standard errors were estimated with a block jackknife over all variants.
We estimated the proportion of variance explained by the set of all conditionally independently associated variants. The joint effects of variants in Polygenic scoring. PRS were computed using LDpred 66 , which accounts for linkage disequilibrium between variants. Since we do not know the variancecovariance matrix of the effects in the training sample (here, the GWAS results), we replace this matrix with a block diagonal matrix estimated using LD patterns from the prediction cohorts, after dropping cryptically related individuals and ancestry outliers.
Smoking and alcohol use rates are influenced by secular trends and policy changes over the past half-century. We therefore selected two independent prediction cohorts, the HRS 21 and Add Health 20 . The HRS is a nationally representative study of US households that began in 1992; the mean birth year of respondents is 1938 (s.d. = 9.3), and the mean age at the time of assessment is 57.6 (s.d. = 8.9). Add Health is a nationally representative sample of US adolescents enrolled in grades 7 through 12 during the 1994-1995 school year. The mean birth year of respondents was 1979 (s.d. = 1.8), and the mean age at assessment (here, wave 4) was 29.0 (s.d. = 1.8). In the HRS, ~57% of respondents reported ever smoking regularly, and these respondents smoked ~13 cigarettes per day. In Add Health, slightly fewer (~53%) of respondents reported ever smoking regularly, and these respondents smoked ~11 cigarettes per day on average ( Supplementary Table 14 ). For each of our five phenotype scores, we used variants that overlapped with HapMap3 (~1.1 million) to construct the scores. Prediction accuracy was estimated using ordinary least squares regression of a given phenotype (AgeSmk, CigDay, SmkInit, SmkCes, or DrnkWk) on the polygenic score and covariates including age, sex, age × sex interaction, and the first ten genetic principal components.
Prediction accuracy comes from a two-step process in which we first regress the phenotype on a standard set of covariates without including the PRS. Then, the PRS predictor is added, and the difference in the coefficient of determination (R 2 ) is calculated. For our quantitative phenotypes, AgeSmk, CigDay, and DrnkWk, the predictive power of the PRS is the change in the R 2 in going from the regression without the PRS to the regression with the PRS. For our two binary phenotypes, SmkInit and SmkCes, we measure the incremental pseudo-R 2 from probit regressions. 95% confidence intervals around all R 2 values are bootstrapped with 1,000 repetitions each. The same polygenic scoring procedure was applied to the MTAG results ( Supplementary Table 32 ).
Epigenomic enrichment.
To detect genome-wide functional and tissue-specific epigenomic enrichments, we performed enrichment analyses by heritability stratification using LD score regression, implemented in the LDSC v.1.0.0 software. Annotation-stratified LD scores were estimated using dichotomized/ binary annotations, 1000 Genomes Project samples with European ancestry, and 1 million-base pair LD windows by default. LDSC then determines functional enrichment of the GWAS traits by partitioning heritability according to the variance explained by the LD-linked SNPs belonging to each functional category 22 . Statistical enrichment was defined as the ratio between the percentage of heritability explained by variants in each annotated category and the percentage of variants covered by that category. A resampling approach was used to estimate standard errors 22 .
Following standard procedure, we trained a baseline LDSC model using the 52 non-cell-type-specific functional categories (plus one category that includes all SNPs) and used the observed Z-scores of HapMap3 SNPs for each trait. We tested cell-group enrichments over 10 predefined cell-group annotations 22 . The cell-group annotations are the result of aggregating 220 cell-type-specific annotations over 4 histone marks (H3K4me1, H3K4me3, H3K9ac, H3K27ac) and 100 well-defined cell types. To detect which specific epigenomes contribute to the group-level enrichment, we performed 220 tests over each individual annotation. Multiple testing was accounted for through Bonferroni correction within phenotype with 10 tests for the cell-group annotation enrichment analyses and 220 tests for the cell-specific enrichment analyses. As a complementary method to LDSC, we also applied a recently developed mixture model learning approach 67 , and we report these results in Supplementary Fig. 13 .
Gene and gene-set tests.
For each phenotype, we used SEQMINER 68 and the University of California, Santa Cruz genome browser annotations (refGene; retrieved 15 December 2017) to annotate all conditionally independent genome-wide significant variants. We identified all genes (all variants 5′ to 3′ UTR) harboring at least one variant within LD r 2 > 0.3 with any conditionally independent variant. See Supplementary Tables 1-5 .
We conducted a manual review of all genes implicated within each locus, overlap with the GWAS catalog ( Supplementary Table 33 ), and all pathways identified by PASCAL and DEPICT (described below). We considered a gene to be implicated if it harbored variation in LD with a conditionally independent genome-wide significant variant, or if a gene was located within the locus and was significant by the PASCAL gene-based test. PASCAL 69 was used for genebased and pathway analysis to test genes and canonical pathways from MSigDb ( Supplementary Tables 20 and 21 ). Default settings were used to test all variants within all genes. DEPICT 70 was used to identify enrichment within tissues/cell types and reconstituted gene sets (also known as pathways). For each phenotype, variants from the GWAS were clumped using 500-kilobase flanking regions with the LD cutoff r 2 > 0.1 (based on 1000 Genomes phase 1 release v.3, the default in DEPICT). We used DEPICT to understand genetic signals beyond the genomewide significant loci that surpass the conventional 5 × 10 −8 , and so included all variants with P < 5 × 10 −5 . DEPICT tissue enrichment results are displayed in Supplementary Fig. 15 , where enrichment relative to genes in random sets of loci is indicated by red shading. To cluster DEPICT reconstituted gene sets, we used affinity propagation clustering 71 and calculated the correlation between each resulting 'exemplary gene set' in Fig. 4 . Genes, gene sets, and tissue/cell enrichments were considered significant when their false discovery rate was below 0.05. All such significant DEPICT results are reported in Supplementary Tables  17-19 . PASCAL and DEPICT were also applied in the same fashion to the MTAG summary statistics ( Supplementary Tables 34-39 ).
Statistics. The GWAS meta-analysis was conducted using χ 2 statistics based upon an imputation-quality-aware fixed-effect meta-analysis approach. Two-sided P values were calculated. The MTAG and GenomicSEM analysis test statistics were determined using the GWAS meta-analysis results, and two-sided P values were similarly calculated from the χ 2 distribution. The pleiotropic analysis was conducted based upon an empirical Bayes approach. The prior distributions for the effect sizes were assumed to follow a mixture distribution, with a point mass at zero (representing the possibility that the locus is not associated with the trait) and a normal distribution (representing the possibility that the locus is associated). The hyperparameters were estimated by maximizing the marginal likelihood. The method properly accounts for the local genetic correlation and residual correlation between phenotypes. The posterior probability of association (PPA) for each locus was estimated for each possible combination of five phenotypes, and the combination with the highest PPA was reported for each locus. 
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Data analysis
All studies used either ShapeIt2, EAGLE or Finch to phase genotypes and used either Minimac3 or IMPUTE2V3 for imputation. Summary statistics were generated using RVTESTS release v1.9.7 or v1.9.9 or BOLT-LMM v2.2. Meta-analysis and conditional analysis was performed using rareGWAMA_0.4 in R. LD Score Regression v1.0.0 was used to measure heritability, test for population stratification and cryptic relatedness, estimate genetic correlations and enrichment analyses. RiVIERA-ridge was also used for enrichment analyses. LDpred v0.9.09 was used to construct the polygenic scores. PASCAL was used for gene based and pathway analysis and DEPICT was used to identify enrichment within tissues/cell types and reconstituted gene sets. Locuszoom plots were made using LocusZoom standalone software v1.3. GenomicSEM was used for the Genomic SEM analyses. MTAG software was used for the MTAG analysis.
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